Results 91 to 100 of about 3,412,012 (256)

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola, Yasmine Illi, Anna Bircher, Marijn Wilmink, Rachele F. Malagutti, Solenn Ottié, Cordelia Schuler, Pedro A. Ruiz, Cheryl de Vallière, Klaus Seuwen, Gerhard Rogler, Martin Hausmann   +11 more
wiley   +1 more source

Volume 1, Issue 4

Emerging Infectious Diseases, 1995
doaj   +1 more source

Erratum: Publisher Correction to: Global Health Research and Policy, volume 4. [PDF]

Glob Health Res Policy, 2019
Global Health Research and Policy.
europepmc   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Corrigendum to "Seeing Artery and VEin Simultaneously in the long axis (SAVES) for ultrasound-guided infraclavicular axillary/subclavian vein cannulation: A retrospective analysis" [Journal of Intensive Medicine volume 4 (2025) 350-358.]. [PDF]

J Intensive Med
Zhang R, Li L, Tang Y, Chen D.
europepmc   +1 more source

BioTM Buzz Volume 4, Issue 2. [PDF]

Bioeng Transl Med, 2019
Anselmo AC.
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Editorial: Volume 14, Number 4

International Review of Research in Open and Distributed Learning, 2013
Dianne Conrad
doaj   +1 more source

Corrigendum to '2025 SCAI/HRS Clinical Practice Guidelines on Transcatheter Left Atrial Appendage Occlusion': [Journal of the Society for Cardiovascular Angiography & Interventions. Volume 4, Issue 9 (2025) 103783]. [PDF]

J Soc Cardiovasc Angiogr Interv
Goldsweig AM, Glikson M, Joza J, Kavinsky CJ, Khalique O, Lakkireddy D, Mackensen GB, Naccarelli GV, Nair DG, Saw J, Sharma RP, Sherwood M, Szerlip M, Falck-Ytter Y, Morgan RL, Armah C, Firestone S, Fix A, Senerth E, Ellis CR.   +19 more
europepmc   +1 more source

Volume Index for Volume 4

Rocky Mountain Journal of Mathematics, 1994
openaire   +2 more sources